Company intelligence / Profile preview

Kenkoderm

Langhorne, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Kenkoderm offers a dermatologist-developed, over-the-counter skincare line for psoriasis, focusing on topical and oral non-steroidal, non-biologic therapies, including soap, cream (containing 2% salicylic acid), shampoo, conditioner, and multivitamins. The line is profitable, sold mainly direct-to-consumer, and rated highly by users.

Therapeutic areas: Dermatology
Modalities: Non-pharmacological therapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Kenkoderm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kenkoderm.

Explore the full profile